DE647244C - Roentgenologisches Verfahren - Google Patents
Roentgenologisches VerfahrenInfo
- Publication number
- DE647244C DE647244C DE1930647244D DE647244DD DE647244C DE 647244 C DE647244 C DE 647244C DE 1930647244 D DE1930647244 D DE 1930647244D DE 647244D D DE647244D D DE 647244DD DE 647244 C DE647244 C DE 647244C
- Authority
- DE
- Germany
- Prior art keywords
- roentgenological
- procedure
- acid
- urinary tract
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 4
- 150000003839 salts Chemical class 0.000 claims description 5
- 210000001635 urinary tract Anatomy 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 210000000244 kidney pelvis Anatomy 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- RDFJFVXMRYVOAC-UHFFFAOYSA-N methiodal Chemical class OS(=O)(=O)CI RDFJFVXMRYVOAC-UHFFFAOYSA-N 0.000 description 1
- 229960003695 methiodal Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE647244T | 1930-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE647244C true DE647244C (de) | 1937-06-30 |
Family
ID=6580954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1930647244D Expired DE647244C (de) | 1930-06-10 | 1930-06-10 | Roentgenologisches Verfahren |
Country Status (5)
| Country | Link |
|---|---|
| AT (1) | AT128587B (en(2012)) |
| CH (1) | CH161431A (en(2012)) |
| DE (1) | DE647244C (en(2012)) |
| DK (1) | DK48099C (en(2012)) |
| NL (1) | NL31804C (en(2012)) |
-
1930
- 1930-06-10 DE DE1930647244D patent/DE647244C/de not_active Expired
-
1931
- 1931-06-08 DK DK48099D patent/DK48099C/da active
- 1931-06-09 NL NL57214A patent/NL31804C/xx active
- 1931-06-09 CH CH161431D patent/CH161431A/de unknown
- 1931-06-09 AT AT128587D patent/AT128587B/de active
Also Published As
| Publication number | Publication date |
|---|---|
| NL31804C (en(2012)) | 1934-01-15 |
| AT128587B (de) | 1932-06-10 |
| DK48099C (da) | 1933-12-04 |
| CH161431A (de) | 1933-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE647244C (de) | Roentgenologisches Verfahren | |
| DE2020348C3 (de) | Träger für ein szintigraphisches Präparat und dessen Verwendung | |
| Gómez Zapata et al. | Study of postmortem blood circulation | |
| Latham | General remarks on the practice of medicine | |
| DE652594C (de) | Roentgenologisches Verfahren | |
| DE735441C (de) | Roentgenkontrastmittel | |
| Heathcote et al. | Per-Abrodil (Pelviren D): an experimental investigation | |
| McNee | Cortisone and ACTH: The present position in America | |
| Babkin et al. | Structure and reactions to stimuli of arteries (and conus) in the elasmobranch genus Raja | |
| AT129942B (de) | Kontrastmittel für Röntgendurchleuchtungen. | |
| Blake | Observations and experiments on the mode in which various poisonous agents act on the animal body | |
| DE674710C (de) | Verfahren zur Gewinnung von blutdrucksenkenden Stoffen | |
| KAWAI et al. | Transient myocardial damage secondary to extravasation of contrast material during left ventricular angiocardiography | |
| Bell | On The Part Played By The Calcium Salts In The Blood And Tissues, With Special Reference To Their Influence In Regard To The Female Genital Functions; Together With A Description Of A Simple Method Of Quantitative Analysis | |
| Steinert | Effect of enemata on contrast excretion in urography | |
| DE904652C (de) | Verfahren zur Herstellung konzentrierter, haltbarer waessriger Loesungen von Furanochromonen | |
| Gardner et al. | An experimental investigation of Uroselectan B | |
| DE633377C (de) | Verfahren zur Gewinnung diuresefoerdernder und diuresehemmender Stoffe | |
| Benjamens et al. | General introduction and outline of this thesis | |
| DE346200C (de) | Verfahren zur Erhaltung und Steigerung der Heilwirkung von Mineralschlamm | |
| AT152976B (de) | Verfahren zur Beurteilung der Wirksamkeit von Mitteln zur Behandlung der perniciösen Anämie. | |
| CH165420A (de) | Verfahren zur Gewinnung einer hochkonzentrierten wässerigen Lösung eines Salzes der 3.5-Dijod-2-pyridon-N-essigsäure. | |
| Smith | The Centenary of a Unique Discovery | |
| AT64787B (de) | Verfahren zur Herstellung eines Krebsheilmittels. | |
| DE2536008C3 (de) | Verfahren zur Herstellung von zur Bindung von Technetium geeigneten zinnhaltigen Humanserumalbumin-Partikeln |